Verve Therapeutics shares owned by MPM Oncology Impact Management
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by MPM Oncology Impact Management
from 13F filings
Historical chart of MPM Oncology Impact Management investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by MPM Oncology Impact Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $3.1M | 638k | 4.88 |
| 2024-03-31 | $8.5M | 638k | 13.28 |
| 2023-09-30 | $11M | 858k | 13.26 |
| 2023-06-30 | $16M | 858k | 18.75 |
| 2023-03-31 | $12M | 804k | 14.42 |
| 2022-12-31 | $16M | 809k | 19.35 |
| 2022-09-30 | $22M | 636k | 34.35 |
More positions owned by MPM Oncology Impact Management
View all positions for MPM Oncology Impact Management